NBRV insider transactions
Nabriva Therapeutics plc (NBRV) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
NBRV insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Nabriva Therapeutics plc, latest first. Follow anyone to get their next filing.
- H Michael Hogan IIIOfficer, since July 2023
- David MaggioOfficer, since June 2023
- Steven P. GeloneDirector
- Theodore R SchroederDirector+$114K
- Daniel DolanOfficer, since March 2021
- J. Christopher NaftzgerOfficer, since September 2021+$4,130
- Christine J. Guico-PabiaOfficer, since October 2021
- Daniel D BurgessDirector-$2,156
- Colin MD BroomDirector-$1,653
- Stephen W WebsterDirector-$2,419
- Mark CorriganDirector-$1,956
- Charles A Rowland JrDirector-$2,419
- Carrie L. BourdowDirector-$2,419
- Lisa DaltonDirector, since June 2021
- Robert CrottyOfficer
- Gary SenderOfficer
- Jennifer SchranzOfficer
Recent Form 3, 4, and 5 filings for NBRV
- SEC Form 3 filed by new insider Hogan H Michael Iii3 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 3 filed by new insider Maggio David3 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 140 units of Ordinary Shares, decreasing direct ownership by 0.97% to 14,283 units to cover taxes4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 431 units of Ordinary Shares, decreasing direct ownership by 3% to 11,989 units to satisfy tax liability4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.03% to 14,423 units (for withholding tax)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 11 units of Ordinary Shares, decreasing direct ownership by 0.09% to 12,420 units to satisfy withholding obligation4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.04% to 12,431 units (for tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 3 units of Ordinary Shares, decreasing direct ownership by 0.02% to 14,428 units (tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 4 units of Ordinary Shares, decreasing direct ownership by 0.03% to 14,431 units to cover taxes4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 9 units of Ordinary Shares, decreasing direct ownership by 0.07% to 12,436 units (for tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 3 units of Ordinary Shares, decreasing direct ownership by 0.02% to 14,435 units (tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.04% to 12,445 units (tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 4 units of Ordinary Shares, decreasing direct ownership by 0.03% to 14,438 units to satisfy tax liability4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 10 units of Ordinary Shares, decreasing direct ownership by 0.08% to 12,450 units (for withholding tax)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.04% to 12,460 units to cover taxes4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 3 units of Ordinary Shares, decreasing direct ownership by 0.02% to 14,442 units to satisfy tax liability4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 9 units of Ordinary Shares, decreasing direct ownership by 0.07% to 12,465 units to satisfy withholding tax4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 4 units of Ordinary Shares, decreasing direct ownership by 0.03% to 14,445 units to satisfy withholding obligation4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 3 units of Ordinary Shares, decreasing direct ownership by 0.02% to 14,449 units (withholding tax)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.04% to 12,474 units to cover taxes4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 311,977 units (tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,311 units to cover withholding tax4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 312,202 units (for withholding tax)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,400 units to satisfy withholding tax4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4 filed by Schroeder Theodore R4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4 filed by Gelone Steven P.4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4 filed by Dolan Daniel4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4 filed by Naftzger J. Christopher4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4 filed by Guico-Pabia Christine J.4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,461 units to cover withholding tax4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 312,309 units to satisfy withholding obligation4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Burgess Daniel D sold $2,156 worth of Ordinary Shares (11,341 units at $0.19), decreasing direct ownership by 52% to 10,384 units4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Broom Colin Md sold $1,015 worth of Ordinary Shares (5,339 units at $0.19), decreasing direct ownership by 13% to 36,523 units4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Webster Stephen W sold $1,487 worth of Ordinary Shares (7,826 units at $0.19), decreasing direct ownership by 41% to 11,447 units4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Corrigan Mark sold $1,956 worth of Ordinary Shares (10,297 units at $0.19), decreasing direct ownership by 59% to 7,203 units4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Rowland Charles A Jr sold $1,487 worth of Ordinary Shares (8,496 units at $0.17), decreasing direct ownership by 36% to 15,277 units4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Bourdow Carrie L. sold $1,487 worth of Ordinary Shares (8,540 units at $0.17), decreasing direct ownership by 46% to 9,933 units4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Dalton Lisa covered exercise/tax liability with 8,400 units of Ordinary Shares, decreasing direct ownership by 48% to 9,100 units to cover taxes4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 312,534 units (for tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,550 units to cover taxes4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 312,641 units (withholding obligation)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,611 units to satisfy tax liability4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 312,866 units to satisfy withholding tax4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,700 units (for tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 312,973 units (withholding tax)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,761 units to cover taxes4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 313,198 units to satisfy withholding tax4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,850 units to cover withholding tax4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,911 units to cover withholding tax4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 313,305 units (for tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 313,530 units (withholding obligation)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,000 units (tax withholding)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 219 units of Ordinary Shares, decreasing direct ownership by 0.07% to 313,637 units (for tax liability)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,061 units to cover taxes4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 104 units of Ordinary Shares, decreasing direct ownership by 0.03% to 313,856 units (tax withholding)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,150 units (withholding obligation)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,211 units (withholding tax)4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 263 units of Ordinary Shares, decreasing direct ownership by 0.08% to 313,960 units to satisfy tax liability4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 125 units of Ordinary Shares, decreasing direct ownership by 0.04% to 314,223 units to satisfy withholding obligation4 - Nabriva Therapeutics plc (0001641640) (Issuer)
- SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,300 units to satisfy withholding obligation4 - Nabriva Therapeutics plc (0001641640) (Issuer)